| Brand | Active ingredient | Application holder | Expiry | Excl. |
|---|---|---|---|---|
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 29 Mar | - |
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 27 Apr | - |
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 21 Jun | - |
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 15 Sept | - |
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 04 Nov | - |
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 17 Nov | - |
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 25 Nov | - |
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 18 Dec | - |
| ACETAMINOPHEN | ACETAMINOPHEN | FRESENIUS KABI USA LLC | 19 Apr | - |
| ACUVUE THERAVISION WITH KETOTIFEN | KETOTIFEN FUMARATE | JOHNSON AND JOHNSON VISION CARE INC | 27 Jun | - |
| AIRSUPRA | ALBUTEROL SULFATE; BUDESONIDE | ASTRAZENECA PHARMACEUTICALS LP | 28 May | M-317 |
| AKYNZEO | NETUPITANT; PALONOSETRON HYDROCHLORIDE | HELSINN HEALTHCARE SA | 18 Nov | - |
| AKYNZEO | FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE | HELSINN HEALTHCARE SA | 17 Dec | - |
| ALECENSA | ALECTINIB HYDROCHLORIDE | HOFFMANN-LA ROCHE INC | 09 Jun | ODE-477 |
| AMONDYS 45 | CASIMERSEN | SAREPTA THERAPEUTICS INC | 12 Nov | ODE-347 |
| AMZEEQ | MINOCYCLINE HYDROCHLORIDE | JOURNEY MEDICAL CORP | 01 Oct | - |
| ANJESO | MELOXICAM | BAUDAX BIO INC | 26 May | - |
| ANORO ELLIPTA | UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND | 29 Nov | - |
| APADAZ | ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | ZEVRA THERAPEUTICS | 01 Jul | - |
| APRISO | MESALAMINE | SALIX PHARMACEUTICALS INC | 01 May | - |
| APTIOM | ESLICARBAZEPINE ACETATE | SUMITOMO PHARMA AMERICA INC | 17 Apr | - |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 24 Jun | - |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 26 Oct | - |
| ARISTADA INITIO KIT | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 24 Jun | - |
| ARISTADA INITIO KIT | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 26 Oct | - |
| AUBAGIO | TERIFLUNOMIDE | SANOFI AVENTIS US LLC | 14 Sept | - |
| AURYXIA | FERRIC CITRATE | KERYX BIOPHARMACEUTICALS INC | 21 Jul | - |
| AVYCAZ | AVIBACTAM SODIUM; CEFTAZIDIME | ABBVIE INC | 08 Oct | NPP |
| BESIVANCE | BESIFLOXACIN HYDROCHLORIDE | BAUSCH AND LOMB INC | 12 Mar | - |
| BESIVANCE | BESIFLOXACIN HYDROCHLORIDE | BAUSCH AND LOMB INC | 07 Nov | - |
| BEVESPI AEROSPHERE | FORMOTEROL FUMARATE; GLYCOPYRROLATE | ASTRAZENECA PHARMACEUTICALS LP | 28 May | - |
| BEVYXXA | BETRIXABAN | PORTOLA PHARMACEUTICALS INC | 28 Dec | - |
| BEYAZ | DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM | BAYER HEALTHCARE PHARMACEUTICALS INC | 08 Feb | - |
| BEYAZ | DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM | BAYER HEALTHCARE PHARMACEUTICALS INC | 17 Jul | - |
| BRAFTOVI | ENCORAFENIB | ARRAY BIOPHARMA INC | 26 Feb | ODE-445 |
| BRAFTOVI | ENCORAFENIB | ARRAY BIOPHARMA INC | 27 Feb | ODE-445 |
| BRAFTOVI | ENCORAFENIB | ARRAY BIOPHARMA INC | 27 Aug | ODE-445 |
| BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE | 08 Mar | - |
| BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE | 08 Sept | PED |
| BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE | 11 Oct | - |
| BREXAFEMME | IBREXAFUNGERP CITRATE | GLAXOSMITHKLINE LLC | 28 Aug | GAIN |
| BREZTRI AEROSPHERE | BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | ASTRAZENECA AB | 28 May | - |
| BRILINTA | TICAGRELOR | ASTRAZENECA PHARMACEUTICALS LP | 17 Apr | - |
| BRILINTA | TICAGRELOR | ASTRAZENECA PHARMACEUTICALS LP | 17 Oct | - |
| BRIVIACT | BRIVARACETAM | UCB INC | 09 Apr | - |
| BYDUREON BCISE | EXENATIDE SYNTHETIC | ASTRAZENECA AB | 04 Oct | - |
| BYSANTI | MILSAPERIDONE | VANDA PHARMACEUTICALS INC | 05 Apr | NCE |
| BYSANTI | MILSAPERIDONE | VANDA PHARMACEUTICALS INC | 24 Jul | NCE |
| BYSANTI | MILSAPERIDONE | VANDA PHARMACEUTICALS INC | 22 Sept | NCE |
| BYSANTI | MILSAPERIDONE | VANDA PHARMACEUTICALS INC | 28 Oct | NCE |
| BYSANTI | MILSAPERIDONE | VANDA PHARMACEUTICALS INC | 17 Dec | NCE |
| CABOMETYX | CABOZANTINIB S-MALATE | EXELIXIS INC | 15 Jan | ODE-530 |
| CABOMETYX | CABOZANTINIB S-MALATE | EXELIXIS INC | 08 Oct | ODE-530 |
| CALDOLOR | IBUPROFEN | APOTEX INC | 14 Sept | NPP |
| CERDELGA | ELIGLUSTAT TARTRATE | GENZYME CORP | 24 Nov | - |
| CHILDREN'S ALLEGRA ALLERGY | FEXOFENADINE HYDROCHLORIDE | CHATTEM INC DBA SANOFI CONSUMER HEALTHCARE | 02 Aug | - |
| CHILDREN'S ALLEGRA HIVES | FEXOFENADINE HYDROCHLORIDE | CHATTEM INC DBA SANOFI CONSUMER HEALTHCARE | 02 Aug | - |
| COBENFY | TROSPIUM CHLORIDE; XANOMELINE TARTRATE | BRISTOL-MYERS SQUIBB CO | 21 Jul | NCE |
| COMETRIQ | CABOZANTINIB S-MALATE | EXELIXIS INC | 15 Jan | - |
| COMETRIQ | CABOZANTINIB S-MALATE | EXELIXIS INC | 08 Oct | - |
| CONTRAVE | BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 02 Feb | - |
| COTELLIC | COBIMETINIB FUMARATE | GENENTECH INC | 10 May | ODE-416 |
| CUBICIN RF | DAPTOMYCIN | CUBIST PHARMACEUTICALS LLC | 23 Nov | - |
| CYCLOSET | BROMOCRIPTINE MESYLATE | VEROSCIENCE LLC | 07 Jun | - |
| DEXILANT | DEXLANSOPRAZOLE | TAKEDA PHARMACEUTICALS USA INC | 17 Mar | - |
| DEXILANT | DEXLANSOPRAZOLE | TAKEDA PHARMACEUTICALS USA INC | 17 Sept | - |
| DEXTENZA | DEXAMETHASONE | OCULAR THERAPEUTIX INC | 12 Feb | NPP |
| DEXTENZA | DEXAMETHASONE | OCULAR THERAPEUTIX INC | 14 May | NPP |
| DOVATO | DOLUTEGRAVIR SODIUM; LAMIVUDINE | VIIV HEALTHCARE CO | 08 Jun | NPP |
| DSUVIA | SUFENTANIL CITRATE | VERTICAL PHARMACEUTICALS LLC | 16 Mar | - |
| DSUVIA | SUFENTANIL CITRATE | VERTICAL PHARMACEUTICALS LLC | 22 Oct | - |
| EDARBYCLOR | AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE | AZURITY PHARMACEUTICALS INC | 04 Feb | - |
| ELLA | ULIPRISTAL ACETATE | LABORATOIRE HRA PHARMA | 13 Apr | - |
| ELLA | ULIPRISTAL ACETATE | LABORATOIRE HRA PHARMA | 02 Jun | - |
| ELLA | ULIPRISTAL ACETATE | LABORATOIRE HRA PHARMA | 12 Jun | - |
| EMBLAVEO | AVIBACTAM SODIUM; AZTREONAM | ABBVIE INC | 08 Oct | GAIN |
| ENTEREG | ALVIMOPAN | CUBIST PHARMACEUTICALS INC | 12 Feb | - |
| EPCLUSA | SOFOSBUVIR; VELPATASVIR | GILEAD SCIENCES INC | 13 Sept | PED |
| EPCLUSA | SOFOSBUVIR; VELPATASVIR | GILEAD SCIENCES INC | 11 Dec | PED |
| ESBRIET | PIRFENIDONE | LEGACY PHARMA INC SEZC | 08 Jan | - |
| EUCRISA | CRISABOROLE | ANACOR PHARMACEUTICALS INC | 20 Jan | D-191 |
| EUCRISA | CRISABOROLE | ANACOR PHARMACEUTICALS INC | 20 Jul | D-191 |
| EVOMELA | MELPHALAN HYDROCHLORIDE | ACROTECH BIOPHARMA INC | 28 May | - |
| EVOMELA | MELPHALAN HYDROCHLORIDE | ACROTECH BIOPHARMA INC | 14 Jun | - |
| EXEM FOAM KIT | AIR POLYMER-TYPE A | GISKIT PHARMA BV | 15 Oct | - |
| EXXUA | GEPIRONE HYDROCHLORIDE | FABRE KRAMER PHARMACEUTICALS INC | 02 Sept | NCE |
| FABIOR | TAZAROTENE | MAYNE PHARMA LLC | 24 Feb | - |
| FANAPT | ILOPERIDONE | VANDA PHARMACEUTICALS INC | 05 Apr | I-939 |
| FANAPT | ILOPERIDONE | VANDA PHARMACEUTICALS INC | 24 Jul | I-939 |
| FANAPT | ILOPERIDONE | VANDA PHARMACEUTICALS INC | 31 Aug | I-939 |
| FANAPT | ILOPERIDONE | VANDA PHARMACEUTICALS INC | 22 Sept | I-939 |
| FANAPT | ILOPERIDONE | VANDA PHARMACEUTICALS INC | 28 Oct | I-939 |
| FANAPT | ILOPERIDONE | VANDA PHARMACEUTICALS INC | 17 Dec | I-939 |
| FARXIGA | DAPAGLIFLOZIN | ASTRAZENECA AB | 26 May | PED |
| FARXIGA | DAPAGLIFLOZIN | ASTRAZENECA AB | 16 Jun | PED |
| FARXIGA | DAPAGLIFLOZIN | ASTRAZENECA AB | 18 Jul | PED |
| FARXIGA | DAPAGLIFLOZIN | ASTRAZENECA AB | 26 Nov | PED |
| FILSPARI | SPARSENTAN | TRAVERE THERAPEUTICS INC | 29 Mar | ODE-493 |
| FILSUVEZ | BIRCH TRITERPENES | CHIESI FARMACEUTICI SPA | 24 Nov | ODE-460 |
| FLOLIPID | SIMVASTATIN | SALERNO PHARMACEUTICALS | 23 Feb | - |
| FOSRENOL | LANTHANUM CARBONATE | TAKEDA PHARMACEUTICALS USA INC | 01 Dec | - |
| FYARRO | SIROLIMUS | AADI BIOSCIENCES INC | 15 Apr | ODE-386 |
| GENOSYL | NITRIC OXIDE | VERO BIOTECH INC | 21 Jun | - |
| GENOSYL | NITRIC OXIDE | VERO BIOTECH INC | 14 Jul | - |
| GENVOYA | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 03 Mar | - |
| GENVOYA | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 30 Apr | - |
| GENVOYA | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 30 Oct | - |
| GIAPREZA | ANGIOTENSIN II ACETATE | LA JOLLA PHARMA LLC | 20 Nov | - |
| GILOTRIF | AFATINIB DIMALEATE | BOEHRINGER INGELHEIM | 10 Apr | - |
| GILOTRIF | AFATINIB DIMALEATE | BOEHRINGER INGELHEIM | 19 Jun | - |
| GILOTRIF | AFATINIB DIMALEATE | BOEHRINGER INGELHEIM | 05 Jul | - |
| GIMOTI | METOCLOPRAMIDE HYDROCHLORIDE | QOL MEDICAL LLC | 16 May | - |
| GLYXAMBI | EMPAGLIFLOZIN; LINAGLIPTIN | BOEHRINGER INGELHEIM | 11 Feb | - |
| GLYXAMBI | EMPAGLIFLOZIN; LINAGLIPTIN | BOEHRINGER INGELHEIM | 14 Apr | - |
| GLYXAMBI | EMPAGLIFLOZIN; LINAGLIPTIN | BOEHRINGER INGELHEIM | 11 Aug | - |
| GOCOVRI | AMANTADINE HYDROCHLORIDE | SUPERNUS PHARMACEUTICALS INC | 02 Dec | - |
| HARVONI | LEDIPASVIR; SOFOSBUVIR | GILEAD SCIENCES INC | 12 May | ODE-262 |
| HARVONI | LEDIPASVIR; SOFOSBUVIR | GILEAD SCIENCES INC | 13 Sept | ODE-262 |
| HARVONI | LEDIPASVIR; SOFOSBUVIR | GILEAD SCIENCES INC | 12 Nov | ODE* |
| HARVONI | LEDIPASVIR; SOFOSBUVIR | GILEAD SCIENCES INC | 11 Dec | ODE* |
| IBSRELA | TENAPANOR HYDROCHLORIDE | ARDELYX INC | 02 May | - |
| IDHIFA | ENASIDENIB MESYLATE | BRISTOL MYERS SQUIBB | 21 Jun | - |
| IDOSE TR | TRAVOPROST | GLAUKOS CORP | 18 Jun | NP |
| IDOSE TR | TRAVOPROST | GLAUKOS CORP | 17 Oct | NP |
| ILEVRO | NEPAFENAC | HARROW EYE LLC | 01 Dec | - |
| IMPLANON | ETONOGESTREL | ORGANON USA LLC | 28 Jul | - |
| IMPOYZ | CLOBETASOL PROPIONATE | PRIMUS PHARMACEUTICALS INC | 31 Aug | - |
| INLEXZO | GEMCITABINE HYDROCHLORIDE | JANSSEN BIOTECH INC | 28 Jun | NP |
| INLEXZO | GEMCITABINE HYDROCHLORIDE | JANSSEN BIOTECH INC | 17 Dec | NP |
| INLYTA | AXITINIB | PF PRISM CV | 14 Dec | - |
| INPEFA | SOTAGLIFLOZIN | LEXICON PHARMACEUTICALS INC | 07 Oct | NCE |
| INQOVI | CEDAZURIDINE; DECITABINE | TAIHO ONCOLOGY INC | 22 Aug | I-990 |
| INTRAROSA | PRASTERONE | MILLICENT PHARMA LTD | 08 Jan | - |
| INVOKAMET | CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE | JANSSEN PHARMACEUTICALS INC | 06 Jul | PED |
| ISENTRESS | RALTEGRAVIR POTASSIUM | MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC | 02 Jun | - |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC | 02 Jun | - |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC | 21 Oct | - |
| ITOVEBI | INAVOLISIB | GENENTECH INC | 27 Sept | NCE |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Feb | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 14 Apr | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Aug | PED |
| JATENZO | TESTOSTERONE UNDECANOATE | TOLMAR INC | 12 Apr | - |
| JATENZO | TESTOSTERONE UNDECANOATE | TOLMAR INC | 20 Dec | - |
| JENTADUETO | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 10 Apr | PED |
| JENTADUETO | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 21 May | PED |
| JENTADUETO | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 04 Jun | PED |
| JENTADUETO | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 21 Nov | PED |
| JENTADUETO | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 04 Dec | PED |
| JENTADUETO XR | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 10 Apr | PED |
| JENTADUETO XR | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 21 May | PED |
| JENTADUETO XR | LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 21 Nov | PED |
| JEVTANA KIT | CABAZITAXEL | SANOFI AVENTIS US INC | 27 Oct | - |
| JUBLIA | EFINACONAZOLE | BAUSCH HEALTH AMERICAS INC | 08 Jul | - |
| JUBLIA | EFINACONAZOLE | BAUSCH HEALTH AMERICAS INC | 24 Oct | - |
| JULUCA | DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE | VIIV HEALTHCARE CO | 08 Jun | - |
| JYNARQUE | TOLVAPTAN | OTSUKA PHARMACEUTICAL CO LTD | 07 Apr | - |
| KALYDECO | IVACAFTOR | VERTEX PHARMACEUTICALS INC | 13 Feb | PED |
| KENGREAL | CANGRELOR | CHIESI USA INC | 10 Nov | - |
| KIMYRSA | ORITAVANCIN DIPHOSPHATE | MELINTA THERAPEUTICS LLC | 26 Apr | - |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 20 Feb | PED |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 25 May | PED |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 09 Jun | PED |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 25 Nov | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 20 Feb | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 25 May | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 09 Jun | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 25 Nov | PED |
| KLISYRI | TIRBANIBULIN | ALMIRALL LLC | 28 Dec | D-192 |
| KOVANAZE | OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE | ST RENATUS LLC | 02 Apr | - |
| KYBELLA | DEOXYCHOLIC ACID | ABBVIE INC | 02 Mar | - |
| KYNMOBI | APOMORPHINE HYDROCHLORIDE | SUMITOMO PHARMA AMERICA INC | 11 Jun | - |
| KYPROLIS | CARFILZOMIB | ONYX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF AMGEN INC | 21 Apr | PED |
| KYZATREX | TESTOSTERONE UNDECANOATE | MARIUS PHARMACEUTICALS INC | 31 Dec | - |
| LENVIMA | LENVATINIB MESYLATE | EISAI INC | 04 Oct | PED |
| LONHALA MAGNAIR KIT | GLYCOPYRROLATE | SUMITOMO PHARMA AMERICA INC | 30 Oct | - |
| LUMIFY | BRIMONIDINE TARTRATE | BAUSCH AND LOMB INC | 14 Jul | - |
| LUMIFY PRESERVATIVE FREE | BRIMONIDINE TARTRATE | BAUSCH AND LOMB INC | 14 Jul | - |
| LUMISIGHT | PEGULICIANINE ACETATE | LUMICELL INC | 01 Sept | NCE |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 10 Jun | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 06 Nov | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 10 Dec | PED |
| MAYZENT | SIPONIMOD | NOVARTIS PHARMACEUTICALS CORP | 30 Nov | - |
| MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | NOVARTIS PHARMACEUTICALS CORP | 15 Oct | PED |
| MEKTOVI | BINIMETINIB | ARRAY BIOPHARMA INC | 27 Aug | I-928 |
| MILPROSA | PROGESTERONE | FERRING PHARMACEUTICALS INC | 21 Jan | - |
| MINIVELLE | ESTRADIOL | NOVEN PHARMACEUTICALS INC | 04 Jul | - |
| MULPLETA | LUSUTROMBOPAG | VANCOCIN ITALIA SRL | 21 Jan | - |
| MYOVIEW 30ML | TECHNETIUM TC-99M TETROFOSMIN KIT | MEDI-PHYSICS INC DBA GE HEALTHCARE | 10 Mar | - |
| MYRBETRIQ | MIRABEGRON | ASTELLAS PHARMA GLOBAL DEVELOPMENT INC | 28 Mar | - |
| NERLYNX | NERATINIB MALEATE | PUMA BIOTECHNOLOGY INC | 24 Mar | - |
| NERLYNX | NERATINIB MALEATE | PUMA BIOTECHNOLOGY INC | 05 Nov | - |
| NERLYNX | NERATINIB MALEATE | PUMA BIOTECHNOLOGY INC | 20 Nov | - |
| NERLYNX | NERATINIB MALEATE | PUMA BIOTECHNOLOGY INC | 29 Dec | - |
| NEUPRO | ROTIGOTINE | UCB INC | 22 Dec | - |
| NEXLETOL | BEMPEDOIC ACID | ESPERION THERAPEUTICS INC | 03 Dec | I-943 |
| NEXLIZET | BEMPEDOIC ACID; EZETIMIBE | ESPERION THERAPEUTICS INC | 03 Dec | I-943 |
| NEXPLANON | ETONOGESTREL | ORGANON USA LLC | 28 Jul | D-199 |
| NITHIODOTE | SODIUM NITRITE; SODIUM THIOSULFATE | HOPE PHARMACEUTICALS | 10 Feb | - |
| NITHIODOTE | SODIUM NITRITE; SODIUM THIOSULFATE | HOPE PHARMACEUTICALS | 07 Jul | - |
| NOCDURNA | DESMOPRESSIN ACETATE | FERRING PHARMACEUTICALS INC | 13 Apr | - |
| NOCTIVA | DESMOPRESSIN ACETATE | ACERUS PHARMACEUTICALS USA LLC | 15 Jun | - |
| NUBEQA | DAROLUTAMIDE | BAYER HEALTHCARE PHARMACEUTICALS INC | 27 Oct | I-971 |
| NUPLAZID | PIMAVANSERIN TARTRATE | ACADIA PHARMACEUTICALS INC | 29 Apr | PED |
| NUPLAZID | PIMAVANSERIN TARTRATE | ACADIA PHARMACEUTICALS INC | 29 Oct | PED |
| NUZOLVENCE | ZOLIFLODACIN | ENTASIS THERAPEUTICS INC | 20 Jun | GAIN |
| NUZYRA | OMADACYCLINE TOSYLATE | PARATEK PHARMACEUTICALS INC | 23 Sept | M-320 |
| NUZYRA | OMADACYCLINE TOSYLATE | PARATEK PHARMACEUTICALS INC | 24 Oct | M-320 |
| OGSIVEO | NIROGACESTAT HYDROBROMIDE | SPRINGWORKS THERAPEUTICS INC | 18 Aug | ODE* |
| OMEPRAZOLE | OMEPRAZOLE | DEXCEL PHARMA TECHNOLOGIES LTD | 31 Jan | - |
| ONGENTYS | OPICAPONE | AMNEAL PHARMACEUTICALS LLC | 31 Mar | - |
| ONPATTRO | PATISIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 21 Oct | M-270 |
| ONPATTRO | PATISIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 10 Nov | M-270 |
| ONUREG | AZACITIDINE | BRISTOL MYERS SQUIBB CO | 03 Jun | ODE-320 |
| ONZETRA XSAIL | SUMATRIPTAN SUCCINATE | AZURITY PHARMACEUTICALS INC | 18 Aug | - |
| ONZETRA XSAIL | SUMATRIPTAN SUCCINATE | AZURITY PHARMACEUTICALS INC | 21 Oct | - |
| ONZETRA XSAIL | SUMATRIPTAN SUCCINATE | AZURITY PHARMACEUTICALS INC | 06 Dec | - |
| ORBACTIV | ORITAVANCIN DIPHOSPHATE | MELINTA THERAPEUTICS LLC | 26 Apr | - |
| ORENITRAM | TREPROSTINIL DIOLAMINE | UNITED THERAPEUTICS CORP | 13 Feb | ODE-272 |
| ORKAMBI | IVACAFTOR; LUMACAFTOR | VERTEX PHARMACEUTICALS INC | 02 Jan | - |
| ORKAMBI | IVACAFTOR; LUMACAFTOR | VERTEX PHARMACEUTICALS INC | 13 Feb | PED |
| ORKAMBI | IVACAFTOR; LUMACAFTOR | VERTEX PHARMACEUTICALS INC | 29 Mar | - |
| ORKAMBI | IVACAFTOR; LUMACAFTOR | VERTEX PHARMACEUTICALS INC | 20 Sept | PED |
| ORKAMBI | IVACAFTOR; LUMACAFTOR | VERTEX PHARMACEUTICALS INC | 11 Dec | - |
| OSMOLEX ER | AMANTADINE HYDROCHLORIDE | SUPERNUS PHARMACEUTICALS INC | 13 Mar | - |
| OTIPRIO | CIPROFLOXACIN | ALK-ABELLO INC | 27 Apr | - |
| OTOVEL | CIPROFLOXACIN HYDROCHLORIDE; FLUOCINOLONE ACETONIDE | LABORATORIOS SALVAT SA | 24 Mar | - |
| OTREXUP | METHOTREXATE | COSETTE PHARMACEUTICALS INC | 19 Mar | - |
| OXYCONTIN | OXYCODONE HYDROCHLORIDE | KNOA PHARMA LLC | 29 Mar | - |
| PARSABIV | ETELCALCETIDE | KAI PHARMACEUTICALS INC A WHOLLY OWNED SUBSIDIARY OF AMGEN INC | 29 Jul | - |
| PENNSAID | DICLOFENAC SODIUM | HORIZON THERAPEUTICS IRELAND DAC | 09 Aug | - |
| PHOSLYRA | CALCIUM ACETATE | FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP LLC | 23 Feb | - |
| POMALYST | POMALIDOMIDE | BRISTOL MYERS SQUIBB CO | 19 May | PED |
| POMALYST | POMALIDOMIDE | BRISTOL MYERS SQUIBB CO | 19 Nov | PED |
| PYLARIFY | PIFLUFOLASTAT F-18 | PROGENICS PHARMACEUTICALS INC | 21 Sept | NCE |
| PYLARIFY TRUVU | PIFLUFOLASTAT F-18 | APHELION LLC | 21 Sept | NCE |
| QBREXZA | GLYCOPYRRONIUM TOSYLATE | JOURNEY MEDICAL CORP | 18 Jul | - |
| QINLOCK | RIPRETINIB | DECIPHERA PHARMACEUTICALS LLC | 27 Jul | ODE-298 |
| QMIIZ ODT | MELOXICAM | TERSERA THERAPEUTICS LLC | 31 Aug | - |
| QTERN | DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE | ASTRAZENECA AB | 16 Jun | - |
| QTERNMET XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | ASTRAZENECA AB | 16 Jun | - |
| QTERNMET XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | ASTRAZENECA AB | 12 Nov | - |
| QUTENZA | CAPSAICIN | AVERITAS PHARMA INC | 26 Mar | - |
| QUZYTTIR | CETIRIZINE HYDROCHLORIDE | ESTEVE PHARMACEUTICALS SA | 11 Feb | - |
| QUZYTTIR | CETIRIZINE HYDROCHLORIDE | ESTEVE PHARMACEUTICALS SA | 28 Feb | - |
| RAVICTI | GLYCEROL PHENYLBUTYRATE | HORIZON THERAPEUTICS US HOLDING LLC | 22 Sept | - |
| RAYALDEE | CALCIFEDIOL | EIRGEN PHARMA LTD | 07 Sept | - |
| RELISTOR | METHYLNALTREXONE BROMIDE | SALIX PHARMACEUTICALS INC | 31 Dec | - |
| RENVELA | SEVELAMER CARBONATE | GENZYME CORP | 06 Dec | - |
| REYVOW | LASMIDITAN SUCCINATE | ELI LILLY AND CO | 07 Jul | - |
| RHOPRESSA | NETARSUDIL MESYLATE | ALCON LABORATORIES INC | 27 Jan | - |
| RHOPRESSA | NETARSUDIL MESYLATE | ALCON LABORATORIES INC | 10 Nov | - |
| ROCKLATAN | LATANOPROST; NETARSUDIL DIMESYLATE | ALCON LABORATORIES INC | 27 Jan | - |
| ROCKLATAN | LATANOPROST; NETARSUDIL DIMESYLATE | ALCON LABORATORIES INC | 10 Nov | - |
| RYDAPT | MIDOSTAURIN | NOVARTIS PHARMACEUTICALS CORP | 02 Dec | - |
| SAFYRAL | DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM | BAYER HEALTHCARE PHARMACEUTICALS INC | 08 Feb | - |
| SAFYRAL | DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM | BAYER HEALTHCARE PHARMACEUTICALS INC | 17 Jul | - |
| SALONPAS | MENTHOL; METHYL SALICYLATE | HISAMITSU PHARMACEUTICAL CO INC | 03 Jan | - |
| SAMSCA | TOLVAPTAN | OTSUKA PHARMACEUTICAL CO LTD | 07 Apr | - |
| SEGLENTIS | CELECOXIB; TRAMADOL HYDROCHLORIDE | KOWA PHARMACEUTICALS AMERICA INC | 19 Apr | - |
| SEGLUROMET | ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE | MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC | 21 Oct | - |
| SERNIVO | BETAMETHASONE DIPROPIONATE | PRIMUS PHARMACEUTICALS INC | 31 Aug | - |
| SILENOR | DOXEPIN HYDROCHLORIDE | CURRAX PHARMACEUTICALS LLC | 07 Sept | - |
| SIMBRINZA | BRIMONIDINE TARTRATE; BRINZOLAMIDE | ALCON LABORATORIES INC | 17 Jun | - |
| SIMBRINZA | BRIMONIDINE TARTRATE; BRINZOLAMIDE | ALCON LABORATORIES INC | 30 Oct | - |
| SITAVIG | ACYCLOVIR | LIGAND PHARMACEUTICALS INC | 16 Jun | - |
| SIVEXTRO | TEDIZOLID PHOSPHATE | CUBIST PHARMACEUTICALS LLC | 03 Feb | NPP |
| SIVEXTRO | TEDIZOLID PHOSPHATE | CUBIST PHARMACEUTICALS LLC | 31 Dec | NPP |
| SODIUM NITRITE | SODIUM NITRITE | HOPE PHARMACEUTICALS | 10 Feb | - |
| SODIUM THIOSULFATE | SODIUM THIOSULFATE | HOPE PHARMACEUTICALS | 10 Feb | - |
| SODIUM THIOSULFATE | SODIUM THIOSULFATE | HOPE PHARMACEUTICALS | 07 Jul | - |
| SOVALDI | SOFOSBUVIR | GILEAD SCIENCES INC | 13 Sept | ODE* |
| SOVALDI | SOFOSBUVIR | GILEAD SCIENCES INC | 11 Dec | ODE* |
| SPINRAZA | NUSINERSEN SODIUM | BIOGEN INC | 17 Jun | NS |
| SPINRAZA | NUSINERSEN SODIUM | BIOGEN INC | 24 Nov | NS |
| SPINRAZA | NUSINERSEN SODIUM | BIOGEN INC | 23 Dec | - |
| STEGLUJAN | ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE | MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC | 21 Oct | - |
| STIVARGA | REGORAFENIB | BAYER HEALTHCARE PHARMACEUTICALS INC | 02 Jun | - |
| STRIBILD | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | GILEAD SCIENCES INC | 03 Mar | - |
| STRIBILD | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | GILEAD SCIENCES INC | 30 Apr | - |
| STRIBILD | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | GILEAD SCIENCES INC | 30 Oct | - |
| SUBOXONE | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | INDIVIOR INC | 26 Mar | - |
| SUBSYS | FENTANYL | BTCP PHARMA LLC | 27 Apr | - |
| SYMBICORT AEROSPHERE | BUDESONIDE; FORMOTEROL FUMARATE | ASTRAZENECA PHARMACEUTICALS LP | 28 May | NS |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Feb | PED |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Aug | PED |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 30 Sept | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Feb | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Aug | PED |
| TAFINLAR | DABRAFENIB MESYLATE | NOVARTIS PHARMACEUTICALS CORP | 20 Jan | PED |
| TAFINLAR | DABRAFENIB MESYLATE | NOVARTIS PHARMACEUTICALS CORP | 20 Jul | PED |
| TAFINLAR | DABRAFENIB MESYLATE | NOVARTIS PHARMACEUTICALS CORP | 15 Oct | PED |
| TAVALISSE | FOSTAMATINIB DISODIUM | RIGEL PHARMACEUTICALS INC | 24 Nov | - |
| TECHNIVIE | OMBITASVIR; PARITAPREVIR; RITONAVIR | ABBVIE INC | 10 Jun | - |
| TEFLARO | CEFTAROLINE FOSAMIL | ABBVIE INC | 21 Sept | - |
| TEPMETKO | TEPOTINIB HYDROCHLORIDE | EMD SERONO INC | 19 Mar | ODE-325 |
| TIBSOVO | IVOSIDENIB | SERVIER PHARMACEUTICALS LLC | 21 Jun | ODE-447 |
| TIVICAY | DOLUTEGRAVIR SODIUM | VIIV HEALTHCARE CO | 08 Jun | - |
| TIVICAY PD | DOLUTEGRAVIR SODIUM | VIIV HEALTHCARE CO | 08 Jun | - |
| TIVORBEX | INDOMETHACIN | GENUS LIFESCIENCES INC | 23 Apr | - |
| TLANDO | TESTOSTERONE UNDECANOATE | VERITY PHARMACEUTICALS INC | 30 Nov | - |
| TOBI PODHALER | TOBRAMYCIN | VIATRIS SPECIALTY LLC | 04 Nov | - |
| TOSYMRA | SUMATRIPTAN | TONIX MEDICINES INC | 16 Jun | - |
| TRADJENTA | LINAGLIPTIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 05 Feb | PED |
| TRADJENTA | LINAGLIPTIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 10 Apr | PED |
| TRADJENTA | LINAGLIPTIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 04 Dec | PED |
| TREANDA | BENDAMUSTINE HYDROCHLORIDE | CEPHALON INC | 23 Mar | - |
| TREANDA | BENDAMUSTINE HYDROCHLORIDE | CEPHALON INC | 26 Oct | - |
| TRELEGY ELLIPTA | FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND | 08 Mar | - |
| TRELEGY ELLIPTA | FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND | 08 Sept | - |
| TRELEGY ELLIPTA | FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND | 11 Oct | - |
| TRELEGY ELLIPTA | FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND | 29 Nov | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Feb | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 14 Apr | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 21 May | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 15 Jun | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Aug | - |
| TRIMBOW | BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | CHIESI FARMACEUTICI SPA | 23 Dec | NP |
| TRIUMEQ | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | VIIV HEALTHCARE CO | 08 Jun | PED |
| TRIUMEQ PD | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | VIIV HEALTHCARE CO | 08 Jun | PED |
| TRUQAP | CAPIVASERTIB | ASTRAZENECA PHARMACEUTICALS LP | 10 Mar | I-991 |
| TWYNEO | BENZOYL PEROXIDE; TRETINOIN | MAYNE PHARMA LLC | 30 Dec | - |
| TYBOST | COBICISTAT | GILEAD SCIENCES INC | 03 Mar | NS |
| TYGACIL | TIGECYCLINE | PF PRISM CV | 08 Oct | - |
| TYVASO DPI | TREPROSTINIL | UNITED THERAPEUTICS CORP | 11 Jun | - |
| UPTRAVI | SELEXIPAG | ACTELION PHARMACEUTICALS US INC | 12 Feb | PED |
| UPTRAVI | SELEXIPAG | ACTELION PHARMACEUTICALS US INC | 25 Jun | PED |
| UPTRAVI | SELEXIPAG | ACTELION PHARMACEUTICALS US INC | 01 Aug | PED |
| UPTRAVI | SELEXIPAG | ACTELION PHARMACEUTICALS US INC | 25 Dec | - |
| VANFLYTA | QUIZARTINIB DIHYDROCHLORIDE | DAIICHI SANKYO INC | 23 Mar | ODE-437 |
| VANFLYTA | QUIZARTINIB DIHYDROCHLORIDE | DAIICHI SANKYO INC | 14 May | ODE-437 |
| VASCEPA | ICOSAPENT ETHYL | AMARIN PHARMACEUTICALS IRELAND LTD | 09 Feb | - |
| VASCEPA | ICOSAPENT ETHYL | AMARIN PHARMACEUTICALS IRELAND LTD | 29 Apr | - |
| VASCEPA | ICOSAPENT ETHYL | AMARIN PHARMACEUTICALS IRELAND LTD | 15 Jun | - |
| VEKLURY | REMDESIVIR | GILEAD SCIENCES INC | 06 Mar | PED |
| VELPHORO | FERRIC OXYHYDROXIDE | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE | 23 Jan | PED |
| VELPHORO | FERRIC OXYHYDROXIDE | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE | 23 Jul | PED |
| VELSIPITY | ETRASIMOD ARGININE | PFIZER INC | 05 Mar | NCE |
| VELTASSA | PATIROMER SORBITEX CALCIUM | VIFOR PHARMA INC | 29 May | NPP |
| VENCLEXTA | VENETOCLAX | ABBVIE INC | 26 May | ODE-239 |
| VEVYE | CYCLOSPORINE | HARROW EYE LLC | 13 Dec | NP |
| VIEKIRA PAK (COPACKAGED) | DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR | ABBVIE INC | 10 Jun | - |
| VIEKIRA XR | DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR | ABBVIE INC | 10 Jun | - |
| VONJO | PACRITINIB CITRATE | SOBI INC | 25 Mar | ODE-397 |
| VOQUEZNA | VONOPRAZAN FUMARATE | PHATHOM PHARMACEUTICALS INC | 10 Apr | GAIN |
| VOQUEZNA | VONOPRAZAN FUMARATE | PHATHOM PHARMACEUTICALS INC | 11 Aug | GAIN |
| VOQUEZNA DUAL PAK | AMOXICILLIN; VONOPRAZAN FUMARATE | PHATHOM PHARMACEUTICALS INC | 10 Apr | GAIN |
| VOQUEZNA DUAL PAK | AMOXICILLIN; VONOPRAZAN FUMARATE | PHATHOM PHARMACEUTICALS INC | 11 Aug | GAIN |
| VOQUEZNA TRIPLE PAK | AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE | PHATHOM PHARMACEUTICALS INC | 10 Apr | GAIN |
| VOQUEZNA TRIPLE PAK | AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE | PHATHOM PHARMACEUTICALS INC | 11 Aug | GAIN |
| VOSEVI | SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR | GILEAD SCIENCES INC | 13 Sept | - |
| VOSEVI | SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR | GILEAD SCIENCES INC | 11 Dec | - |
| VOXZOGO | VOSORITIDE | BIOMARIN PHARMACEUTICAL INC | 20 May | ODE-449 |
| VRAYLAR | CARIPRAZINE HYDROCHLORIDE | ABBVIE INC | 16 Jan | PED |
| VRAYLAR | CARIPRAZINE HYDROCHLORIDE | ABBVIE INC | 17 Mar | PED |
| WAKIX | PITOLISANT HYDROCHLORIDE | HARMONY BIOSCIENCES MANAGEMENT INC | 07 Mar | ODE-519 |
| WINLEVI | CLASCOTERONE | SUN PHARMACEUTICAL INDUSTRIES LTD | 25 Jul | - |
| XARTEMIS XR | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | MALLINCKRODT INC | 21 Dec | - |
| XDEMVY | LOTILANER | TARSUS PHARMACEUTICALS INC | 17 Jan | NCE |
| XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | ASTRAZENECA AB | 26 May | PED |
| XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | ASTRAZENECA AB | 16 Jun | PED |
| XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | ASTRAZENECA AB | 12 Nov | PED |
| XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | ASTRAZENECA AB | 26 Nov | PED |
| XIIDRA | LIFITEGRAST | BAUSCH AND LOMB INC | 21 Oct | - |
| XIIDRA | LIFITEGRAST | BAUSCH AND LOMB INC | 12 Nov | - |
| XOCOVA | ENSITRELVIR | SHIONOGI INC | 12 Dec | NCE |
| XOFLUZA | BALOXAVIR MARBOXIL | GENENTECH INC | 14 Jun | M-187 |
| XOSPATA | GILTERITINIB FUMARATE | ASTELLAS PHARMA US INC | 28 Jul | - |
| XTAMPZA ER | OXYCODONE | COLLEGIUM PHARMACEUTICAL INC | 10 Dec | - |
| XTORO | FINAFLOXACIN | FONSECA BIOSCIENCES LLC | 02 Jul | - |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 19 Mar | - |
| YUPELRI | REVEFENACIN | MYLAN IRELAND LTD | 14 Jul | - |
| YUVEZZI | BRIMONIDINE TARTRATE; CARBACHOL | VISUS THERAPEUTICS INC | 24 May | NP |
| ZECUITY | SUMATRIPTAN SUCCINATE | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC | 19 Nov | - |
| ZELBORAF | VEMURAFENIB | HOFFMANN LA ROCHE INC | 27 Jul | - |
| ZELSUVMI | BERDAZIMER SODIUM | LNHC INC | 20 Aug | NCE |
| ZEPOSIA | OZANIMOD HYDROCHLORIDE | BRISTOL MYERS SQUIBB CO | 15 Nov | M-309 |
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | HARROW EYE LLC | 15 Mar | - |
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | HARROW EYE LLC | 15 Sept | - |
| ZILXI | MINOCYCLINE HYDROCHLORIDE | JOURNEY MEDICAL CORP | 01 Oct | - |
| ZORVOLEX | DICLOFENAC | ZYLA LIFE SCIENCES US INC | 23 Apr | - |
| ZUBSOLV | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EDENBRIDGE PHARMACEUTICALS LLC DBA DEXCEL PHARMA USA | 22 May | - |
| ZUPLENZ | ONDANSETRON | AQUESTIVE THERAPEUTICS INC | 13 Jul | - |
| ZYCLARA | IMIQUIMOD | BAUSCH HEALTH US LLC | 30 Apr | - |
| ZYDELIG | IDELALISIB | GILEAD SCIENCES INC | 11 Mar | - |
| ZYKADIA | CERITINIB | NOVARTIS PHARMACEUTICALS CORP | 29 Jun | - |
Provenance
Source: FDA Orange Book patent and exclusivity files. Rows carrying an exclusivity code have a separate regulatory exclusivity that can outlast the patent shown. Patent expiry alone does not determine when a generic can launch: paediatric extensions, 30-month stays and settlement agreements frequently move the effective date. Delisted patents are excluded.